9/22/2008

A new study found that the somatic mutation in the JAK2 gene may play a role in Down's syndrome-related acute lymphoblastic leukemia. The finding suggests that JAK2 inhibitors help treat the disease, one researcher said.

Full Story:
Medical News Today

Related Summaries